Candesartan cilexetil 4 MG tab 90S
Ended Awarded
- Contract number
- SPE2DR26FM13M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,190
Award facts
- Contract value 100% obligated
- $51,189.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,189.80 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 4 mg tablets (90-count packages) on November 14, 2025, with completion expected by November 17, 2025. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
AmerisourceBergen Drug Corp is a for-profit healthcare solutions provider that functions as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio. The company demonstrates significant capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, with this delivery order representing a routine supply transaction within the larger pharmaceutical prime vendor program that supports the Defense Health Agency and other government healthcare entities worldwide. The DLA Troop Support Medical vehicle under which this award was issued enables flexible pharmaceutical supply operations to support military health programs globally.
Quick answers
Who was awarded contract SPE2DR26FM13M?
SPE2DR26FM13M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FM13M worth?
The government has obligated $51,190 on SPE2DR26FM13M.
Is contract SPE2DR26FM13M an order under another contract?
Yes. SPE2DR26FM13M is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM13M competed?
The extent of competition for SPE2DR26FM13M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award